Pharmacist-led Continuous Glucose Monitoring

Sponsored by University of South Florida

About this trial

Last updated 2 years ago

Study ID

STUDY007451

Status

Recruiting

Type

Observational

Placebo

Accepting

18+ Years

All Sexes

Trial Timing

Ended 9 months ago

What is this trial about?

This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer). 2. to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group) 3. to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)

What are the participation requirements?

Inclusion Criteria

* type 2 diabetes

* hemoglobin A1c ≥ 8%

* compatible smartphone with FreeStyle Libre 2 continuous glucose monitoring system

* current use and access to a glucometer for self-monitoring of blood glucose

Exclusion Criteria

* any continuous glucose monitor use within 6 months prior to study enrollment

* pregnant and planning to become pregnant during study time frame

* history of hypoglycemia requiring third party assistance

* history of diabetic ketoacidosis or hyperosmolar hyperglycemic state within 6 months prior to study enrollment

* known allergy to medical grade adhesives

* current use of systemic steroids for any medical condition

* current use of dialysis